Globe Newswire
MINNEAPOLIS, May 15, 2024 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (OTCQB: PBLA), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, today provides a business update and reports financial results for the quarter ended March 31, 2024. As previously announced, management is hosting earnings call today at 4:30 p.m. ET.
Q1 2024 and recent Highlights:
Clinical
- Announced revised timing for... (continue reading...)
GEORGE TOWN, Cayman Islands, May 15, 2024 (GLOBE NEWSWIRE) -- Consolidated Water Co. Ltd. (NASDAQ Global Select Market: CWCO), a leading designer, builder and operator of advanced water supply and treatment plants, reported results for the first quarter ended March 31, 2024. All comparisons are to the same prior year period unless otherwise noted.
The company will hold a conference call at 11:00 a.m. Eastern time tomorrow to discuss the results (see dial-in... (continue reading...)
ROSEVILLE, Minn., May 15, 2024 (GLOBE NEWSWIRE) -- Hawkins, Inc. (Nasdaq: HWKN), a leading specialty chemical and ingredients company, today announced fourth quarter and full-year results for its fiscal year ended March 31, 2024.
Fourth Quarter Fiscal Year 2024 Highlights:
- Fourth quarter sales of $223.0 million, down 2% compared to the same quarter in the prior year, with Water Treatment segment sales growth of 21% over the same quarter in the prior year.
- Gross... (continue reading...)
CEO Allan Evans shares post-IPO achievements and provides insight into the Company’s strategic expansion into defense sector
ORLANDO, Fla., May 15, 2024 (GLOBE NEWSWIRE) -- Unusual Machines, Inc. (NYSE American: UMAC) (“Unusual Machines” or the “Company”), a drone and drone components manufacturer, today announced it filed its 10-Q with the U.S. Securities and Exchange Commission for the first quarter of 2024 and provided the following letter to its... (continue reading...)
GARDENA, CA, May 15, 2024 (GLOBE NEWSWIRE) -- Polar Power, Inc. (“Polar Power” or the “Company”) (NASDAQ: POLA), a global provider of prime, backup, and solar hybrid DC power solutions, reports its financial results for the first quarter of 2024.
Q1 2024 Financial Highlights
●Net sales of $1.8 million compared to $4.2 million in the same period in 2023●Operating expenses of $1.6 million compared to $1.7 million in the same period in 2023●Net loss was... (continue reading...)More Globe Newswire
View Older Stories-
Agile Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
-
Ingredion Incorporated Declares Quarterly Dividend of $0.78 per Share
-
Robinhood Markets, Inc. Reports April 2024 Operating Data
-
Envoy Medical Reports First Quarter 2024 Results
-
Spero Therapeutics Announces First Quarter 2024 Operating Results and Provides a Business Update
-
Oncocyte Reports First Quarter 2024 Financial Results
-
Inotiv Reports Second Quarter Financial Results for Fiscal 2024 and Provides Business Update
-
PainReform Provides Business Update for the First Quarter of 2024
-
FormFactor Again Named One of THE BEST Suppliers in the Semiconductor Industry
-
STRATA Skin Sciences Reports First Quarter 2024 Financial Results and Provides a Corporate Update
-
Merit Medical Executive Leadership Team Update
-
TOMI Environmental Solutions, Inc. Reports First Quarter 2024 Financial Results
-
Barfresh Provides First Quarter 2024 Results and Business Update
-
Aqua Metals Advances Circular Supply Chain Strategy with Sierra ARC Buildout, Commercial Partnerships, and $40M Capital Infusion, Reports First Quarter 2024 Results
-
Davis Commodities Limited Announces Fiscal Year 2023 Financial Results
-
Armlogi Holding Corp. Announces Closing of $8 Million Initial Public Offering
-
Rezolute Reports Third Quarter Fiscal 2024 Financial Results and Provides Business Update
-
Leslie’s, Inc. Appoints Maile (Clark) Naylor to Board of Directors
-
CDT Environmental Technology Investment Holdings Limited Files Annual Report on Form 20-F
-
Cullinan Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results
-
OrthoPediatrics Corp. Continued Leading Sponsorship at 2024 EPOSNA Annual Meeting
-
Hawkins, Inc. Declares Quarterly Cash Dividend of $0.16 Per Share
-
TILT Holdings Reports First Quarter 2024 Results
-
ReShape Lifesciences® Reports First Quarter Ended March 31, 2024 Financial Results and Provides Corporate Update
-
Athira Pharma Reports First Quarter 2024 Financial Results and Pipeline and Business Updates
-
Dave to Participate in the FT Partners Equity Research Weekly Forum on May 17th
-
Biora Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results
-
Journey Medical Corporation to Participate in the Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company Showcase
-
Mereo BioPharma Reports First Quarter 2024 Financial Results and Provides Corporate Update
-
Navios Maritime Holdings Inc. Provides Important Reminder for All Holders of Series G and Series H American Depositary Shares: Early Tender Deadline to Receive $5.75 in Cash Is May 21, 2024, 5:00 P.M.
-
Kineta Reports First Quarter 2024 Financial Results and Provides Update on its Ongoing Phase 1/2 VISTA-101 Clinical Trial and Corporate Activities
-
Celcuity Inc. Reports First Quarter Financial Results and Provides Corporate Update
-
Cidara Therapeutics Regains Compliance with Nasdaq Continued Listing Rules
-
Monte Rosa Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
-
HRBR Class Action Alert: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Class Acton Against Harbor Diversified, Inc.
-
Eyenovia Reports First Quarter 2024 Financial Results and Provides Updates on its Myopia Phase III Program and its Two FDA Approved Commercial Products, Mydcombi and Clobetasol
-
Apogee Announces Dosing of First Patient in Phase 2 Atopic Dermatitis Trial of APG777, a Novel Subcutaneous Half-life Extended Anti-IL-13 Antibody for the Treatment of Atopic Dermatitis and Other Infl
-
Xometry Appoints Subir Dutt As Chief Sales Officer
-
United Fire Group, Inc. Declares a Common Stock Quarterly Cash Dividend of $0.16 per Share
-
CSX Executive Vice President and Chief Financial Officer to Address Wolfe Research Global Transportation & Industrials Conference
-
IZEA Reports Q1 2024 Revenue of $7.0 million
-
CSX Executive Vice President and Chief Financial Officer to Address Wolfe Research Global Transportation & Industrials Conference
-
Galapagos and Blood Centers of America announce strategic collaboration to accelerate Galapagos’ decentralized CAR-T manufacturing network in the U.S.
-
Five Below, Inc. Announces First Quarter Fiscal 2024 Earnings Release and Conference Call Date
-
authID Inc. Reports Financial and Operating Results for the First Quarter Ended March 31, 2024
-
Q.E.P. Co., Inc. Announces Special Cash Dividend of $1.00 per Share
-
MYR Group Inc. to Participate in Sidoti Small Cap Investor Conference in June
-
Yield10 Bioscience Announces First Quarter 2024 Financial Results
-
Ensemble Health Partners Awarded Tenth U.S. Patent for Latest Innovative Technology, Driving Frictionless Revenue Cycle Management for Healthcare Providers
-
NeuroMetrix Reports Q1 2024 Business Highlights